نتائج البحث

A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a 14 C-Microtracer Approach.

• Authors : Singh RSP; Pfizer Inc, Cambridge, Massachusetts, USA.; Dowty ME

Subjects: Biological Availability*; Administration, Oral ; Feces

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Jul; Vol. 11 (7), pp. 815-825. Date of Electronic Publication: 2022 May 04.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

An Open-Label, Single-Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults.

• Authors : Kato K; Astellas Pharma Inc., Tsukuba, Japan.; den Adel M

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacokinetics ; Oxadiazoles/Oxadiazoles/Oxadiazoles/*pharmacokinetics; Adult

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Jul; Vol. 8 (5), pp. 595-602. Date of Electronic Publication: 2018 Nov 09.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Mass Balance and Metabolite Profile after Single and Multiple Oral Doses of Pritelivir in Healthy Subjects.

• Authors : Bonsmann, Susanne¹ (AUTHOR) ; McCormick, David² (AUTHOR); Pausch, Jörg³ (AUTHOR)

• Source: Clinical Pharmacology in Drug Development. Apr2024, Vol. 13 Issue 4, p389-403. 15p.

تفاصيل العنوان

Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous Infusion.

• Authors : Houk BE; Pfizer Oncology, San Diego, CA, USA.; Alvey CW

Subjects: Morpholines/Morpholines/Morpholines/*pharmacokinetics ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*pharmacokinetics ; Triazines/Triazines/Triazines/*pharmacokinetics

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Jan; Vol. 8 (1), pp. 22-31. Date of Electronic Publication: 2018 Sep 26.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Pharmacokinetics, Excretion, and Mass Balance of [ 14 C]-Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men.

• Authors : Ambery C; Clinical Pharmacology Modelling and Simulation, GSK, Stockley Park West, Uxbridge, Middlesex, UK.; Young G

Subjects: Carbamates/Carbamates/Carbamates/*administration & dosage ; Carbamates/Carbamates/Carbamates/*pharmacokinetics ; Quinolones/Quinolones/Quinolones/*administration & dosage

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2018 Nov; Vol. 7 (8), pp. 901-910. Date of Electronic Publication: 2018 Sep 19.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Pharmacologic and Pharmacodynamic Equivalence of 2 Formulations of Orlistat.

• Authors : Johnson S; GSK Consumer Healthcare, Parsippany, NJ, USA.; Schwartz SM

Subjects: Feces/Feces/Feces/*chemistry ; Lipid Regulating Agents/Lipid Regulating Agents/Lipid Regulating Agents/*administration & dosage ; Lipid Regulating Agents/Lipid Regulating Agents/Lipid Regulating Agents/*pharmacokinetics

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2018 Sep; Vol. 7 (7), pp. 773-780. Date of Electronic Publication: 2018 Apr 16.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy Participants.

• Authors : Yamamiya, Ikuo^1,2 (AUTHOR) ; Hunt, Allen³ (AUTHOR); Yamashita, Fumiaki² (AUTHOR)

• Source: Clinical Pharmacology in Drug Development. Sep2023, Vol. 12 Issue 9, p927-939. 13p.

تفاصيل العنوان

Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study.

• Authors : Johansson SA; AstraZeneca Gothenburg, Mölndal, Sweden.; Knutsson M

Subjects: Isoquinolines/Isoquinolines/Isoquinolines/*administration & dosage ; Phosphorus/Phosphorus/Phosphorus/*metabolism ; Sodium, Dietary/Sodium, Dietary/Sodium, Dietary/*metabolism

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2017 Sep; Vol. 6 (5), pp. 457-465. Date of Electronic Publication: 2017 Mar 24.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism.

• Authors : Lee, Caroline A.¹ (AUTHOR) ; Oh, D. Alexander¹ (AUTHOR); Tang, Yong¹ (AUTHOR)

• Source: Clinical Pharmacology in Drug Development. Jun2023, Vol. 12 Issue 6, p553-571. 19p.

تفاصيل العنوان

Pharmacokinetics, Excretion, and Mass Balance of [14C]‐Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men

• Authors : Teresa Fuller; Claire Ambery; Adam Hughes

Subjects: Adult; Male; microtracer

• Source: Clinical Pharmacology in Drug DevelopmentClin Pharmacol Drug Dev

تفاصيل العنوان